Result of a Cooperative Study with L-Asparaginase in Human Leukemias

Report of the Section “Oncology” of the Paul-Ehrlich-Society for Chemotherapy
  • H. Gerhartz
  • H. Begemann
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 33)

Abstract

Through the Paul-Ehrlich-Society for Chemotherapy, clinical trials of L-asparaginase 1 were conducted in three different programs (Table 1): First, in an orientation trial, an attempt was made to treat all cases of acute leukemias at a constant dose of 200 IU/kg daily intravenously for a period of 4 weeks.

Keywords

Cholesterol Toxicity Lymphoma Leukemia Creatinine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin • Heidelberg 1970

Authors and Affiliations

  • H. Gerhartz
    • 1
  • H. Begemann
    • 1
  1. 1.Hämat.-onkol. Abt. Med. Klinik Westend Freien Universität Berlin u. Med. KlinikKrankenhaus München-SchwabingGermany

Personalised recommendations